Dynamic Anthropometrics in Pancreatic Cancer: Associations Between Body Composition Changes During Neoadjuvant Therapy and Survival Outcomes After Resection-Reference-Cited by-同舟云学术

Dynamic Anthropometrics in Pancreatic Cancer: Associations Between Body Composition Changes During Neoadjuvant Therapy and Survival Outcomes After Resection

Published:2024-08-09 Issue: Volume: Page:
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

Yee Elliott J.,Torphy Robert J.,Myers Emily K.,Meguid Cheryl,Franklin Oskar,Sugawara Toshitaka,Franco Salvador Rodriguez,Clark Toshimasa J.,Mungo Benedetto,Ahrendt Steven A.,Schulick Richard D.,del Chiaro Marco,McCarter Martin M.

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1245/s10434-024-15975-6.pdf

Reference34 articles.

1. Boone BA, Steve J, Zenati MS, et al. Serum CA 19–9 response to neoadjuvant therapy is associated with outcome in pancreatic adenocarcinoma. Ann Surg Oncol. 2014;21:4351–8. https://doi.org/10.1245/s10434-014-3842-z.

2. Argiles JM, Lopez-Soriano FJ, Stemmler B, Busquets S. Cancer-associated cachexia: understanding the tumour macroenvironment and microenvironment to improve management. Nat Rev Clin Oncol. 2023;20:250–64. https://doi.org/10.1038/s41571-023-00734-5.

3. Peixoto da Silva S, Santos JMO, Costa ESMP, Gil da Costa RM, Medeiros R. Cancer cachexia and its pathophysiology: links with sarcopenia, anorexia, and asthenia. J Cachexia Sarcopenia Muscle. 2020;11:619–35. https://doi.org/10.1002/jcsm.12528.

4. Kordes M, Larsson L, Engstrand L, Lohr JM. Pancreatic cancer cachexia: three dimensions of a complex syndrome. Br J Cancer. 2021;124:1623–36. https://doi.org/10.1038/s41416-021-01301-4.

5. Fang P, Zhou J, Xiao X, et al. The prognostic value of sarcopenia in oesophageal cancer: a systematic review and meta-analysis. J Cachexia Sarcopenia Muscle. 2023;14:3–16. https://doi.org/10.1002/jcsm.13126.